comparemela.com

Latest Breaking News On - பல்கலைக்கழகம் ஆஃப் டொராண்டோ ஆன் - Page 1 : comparemela.com

3 more vaccine developers seek trials in PHL

BusinessWorld May 25, 2021 | 8:18 pm PHILIPPINE STAR/ MICHAEL VARCAS THREE more coronavirus vaccine developers applied for clinical trials in the Philippines, the Department of Science and Technology said on Tuesday. In a press briefing, Science and Technology Undersecretary Rowena Cristina L. Guevara said the task group on vaccine evaluation and selection received clinical trial applications from West China Hospital and Sichuan University, Shenzhen Kangtai Biological Products Co., and Eubiologics Co. Ltd. “Evaluation of the first two new applications are ongoing, while Eubiologics Co. Ltd. are still completing some requirements,” she told an online briefing. The applications are for phase III clinical trials, she said.

David Staples: Not enough done to ensure safety of research into deadly viruses

Article content Leading scientists increasingly question whether the Wuhan Lab in China was the source of the coronavirus. The hotly contested issue drives a number of hard questions: How likely are the laboratory leaks of deadly viruses? What is the risk of a man-made pandemic? Should scientists make deadly viruses even more lethal in lab experiments? We apologize, but this video has failed to load. Try refreshing your browser, or David Staples: Not enough done to ensure safety of research into deadly viruses Back to video Debate around this has been heated in scientific circles for decades. A number of scientists are deeply engaged, including Dr. David Evans of the University of Alberta, one of the world’s leading poxvirus researchers, who got worldwide attention in 2016 for synthesizing horsepox, a virus in the smallpox family. Evans has also been involved in biosafety inspections of the highest security labs in Russia and the U.S.

David Staples: Not enough done to ensure safety of research into deadly viruses

Article content Leading scientists increasingly question whether the Wuhan Lab in China was the source of the coronavirus. The hotly contested issue drives a number of hard questions: How likely are the laboratory leaks of deadly viruses? What is the risk of a man-made pandemic? Should scientists make deadly viruses even more lethal in lab experiments? We apologize, but this video has failed to load. Try refreshing your browser, or David Staples: Not enough done to ensure safety of research into deadly viruses Back to video Debate around this has been heated in scientific circles for decades. A number of scientists are deeply engaged, including Dr. David Evans of the University of Alberta, one of the world’s leading poxvirus researchers, who got worldwide attention in 2016 for synthesizing horsepox, a virus in the smallpox family. Evans has also been involved in biosafety inspections of the highest security labs in Russia and the U.S.

Scientists formed EDGI to stop Trump s EPA from wiping out climate data

After hearing the news that then President-elect Donald Trump had appointed a notorious climate change denier to lead the Environmental Protection Agency transition team in 2016, Nicholas Shapiro, an environmental anthropologist, penned an urgent email to a dozen or so fellow scientists. He was worried that the EPA was about to be torn apart from the inside under Trump’s leadership. Others on the email thread were concerned that vital environmental data would be taken down from federal websites and destroyed. They’d just seen brutal attacks on science in Canada irreplaceable scientific records were dumped in the trash under conservative Prime Minister Stephen Harper and they feared that something similar could happen in the US. So Shapiro took a cue from his sister, an organizer for the Women’s March, and tried to bring researchers together to mount an offensive.

Paul Krugman - NOW Magazine

NOW Magazine One hour livestream featuring Paul Krugman (Columnist, The New York Times; Distinguished Professor, City University of New York; Professor Emeritus, Woodrow Wilson School, Princeton University; Nobel Prize-Winning Economist; Bestselling Author) in conversation with Kenneth S. Corts (Interim Dean, Marcel Desautels Chair in Entrepreneurship, and Professor of Economic Analysis and Policy, Rotman School of Management, University of Toronto) on Arguing with Zombies: Economics, Politics, and the Fight for a Better Future M arch 1 from 5 pm-6 pm. Cost:$23.95 + HST per person (includes the link for the livestream and 1 paperback copy of “Arguing with Zombies”) Advance registration required.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.